Three Regeneron Pharmaceuticals, Inc. insiders sell $32.3M of stock within one day
Open-market sales on Nov 2, none marked as part of a 10b5-1 plan.
Form 4 filings show three Regeneron Pharmaceuticals, Inc. insiders selling stock on Nov 2, for a total of $32.3 million.
George L. Sing (director) made the largest sale, $20.4 million at an average of $964.38 a share. Three or more insiders selling within 14 days is what Insider Stock Trader labels a cluster sell.
None of these filings marks the sale as made under a Rule 10b5-1 trading plan. The table below lists who sold, when, and at what price.
Details from the SEC filing:
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| Joseph J Larosa | EVP General Counsel and Secret | Nov 2 | 4,466 | $965.49 | $4,311,890 | App · SEC |
| Christine A. Poon | Director | Nov 2 | 7,830 | $969.09 | $7,587,958 | App · SEC |
| George L. Sing | Director | Nov 2 | 21,129 | $964.38 | $20,376,358 | App · SEC |
| Total | $32,276,206 | |||||
See every insider trade at Regeneron Pharmaceuticals, Inc.
Each row of the table links to its Form 4 on SEC.gov.
Read the daily insider trading roundup · See all the latest insider trades
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
